• LAST PRICE
    26.5900
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    25.2000/ 1
  • Ask / Lots
    30.5000/ 1
  • Open / Previous Close
    --- / 26.5900
  • Day Range
    ---
  • 52 Week Range
    Low 14.3500
    High 36.3700
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 27.41
TimeVolumeAVBP
09:32 ET34827.56
09:35 ET20027.345
09:37 ET10027.345
09:46 ET10027.18
09:48 ET120627.18
09:50 ET93027.325
09:53 ET10027.43
09:55 ET60027.325
10:00 ET10027.46
10:04 ET40027.31
10:09 ET40027.4
10:13 ET10027.39
10:15 ET10027.44
10:20 ET20327.355
10:22 ET2285527.375
10:24 ET3263927.17
10:31 ET55027
10:33 ET10027.03
10:49 ET20027.07
10:51 ET30027.08
11:00 ET100027.27
11:02 ET20027.46
11:05 ET10027.53
11:16 ET35927.41
11:18 ET50027.55
11:27 ET170027.595
11:34 ET20027.765
11:36 ET10027.77
11:39 ET25027.43
11:45 ET10027.615
11:48 ET50027.645
11:52 ET50027.65
11:54 ET20027.645
11:57 ET40027.645
11:59 ET10027.645
12:01 ET20027.645
12:03 ET30027.64
12:06 ET10027.55
12:08 ET20027.54
12:10 ET60027.53
12:12 ET50027.53
12:14 ET50027.51
12:15 ET10027.5
12:17 ET30027.48
12:19 ET54927.51
12:21 ET15127.5
12:24 ET10027.45
12:26 ET21227.5
12:32 ET202127.515
12:33 ET10027.525
12:39 ET20027.525
12:46 ET112527.56
12:48 ET155727.55
12:50 ET10027.63
01:00 ET110027.45
01:02 ET10027.505
01:04 ET10027.465
01:22 ET24527.58
01:24 ET40027.585
01:27 ET10027.64
01:33 ET21927.645
01:36 ET12627.61
01:44 ET40027.52
01:45 ET919427.435
01:51 ET30027.28
01:54 ET70027.36
02:07 ET130027.295
02:09 ET10027.25
02:12 ET50327.21
02:14 ET26027.21
02:30 ET20027.255
02:34 ET20027.255
02:38 ET50027.33
02:39 ET159427.07
02:43 ET60027.06
02:54 ET10027.0136
02:59 ET90026.84
03:03 ET10026.775
03:06 ET32726.775
03:14 ET10026.92
03:17 ET53226.75
03:19 ET307526.58
03:26 ET35026.66
03:28 ET22226.73
03:35 ET40426.84
03:37 ET20026.875
03:39 ET10026.875
03:42 ET100426.755
03:46 ET10026.795
03:48 ET70026.77
03:50 ET20026.845
03:51 ET110826.82
03:53 ET43826.853
03:55 ET43526.84
03:57 ET207026.72
04:00 ET2141826.59
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesAVBP
Arrivent Biopharma Inc
893.0M
-10.1x
---
United StatesNUVB
Nuvation Bio Inc
908.7M
-1.2x
---
United StatesSEPN
Septerna Inc
915.2M
-87,160.0x
---
United StatesBCAX
Bicara Therapeutics Inc
870.1M
0.0x
---
United StatesLENZ
LENZ Therapeutics Inc
943.8M
-4.8x
---
United StatesRAPP
Rapport Therapeutics Inc
823.7M
0.0x
---
As of 2024-11-22

Company Information

ArriVent Biopharma, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. Its lead development candidate, Furmonertinib, and advance a pipeline of novel therapeutics, such as antibody drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors. Furmonertinib is an oral, highly brain-penetrant, active mutation-selective EGFR inhibitor that targets both classical (exon 19 deletion and L858R) and uncommon EGFR mutations, including exon 20 insertion mutations, as well as HER2 exon 20 insertion mutations. Furmonertinib is an investigational, novel, EGFR mutant-selective tyrosine kinase inhibitor that is developing for the treatment of NSCLC patients across a set of EGFR mutations. It is also focused on development and commercialization of the ARR-002 program.

Contact Information

Headquarters
18 Campus Blvd., Suite 100NEWTOWN SQUARE, PA, United States 19073-3269
Phone
240-780-6356
Fax
302-636-5454

Executives

Chairman of the Board, President, Chief Executive Officer
Zhengbin Yao
Chief Financial Officer, Treasurer
Winston Kung
Chief Operating Officer
Robin Lachapelle
Chief Technology Officer
Yang Wang
General Counsel, Secretary
James Kastenmayer

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$893.0M
Revenue (TTM)
$0.00
Shares Outstanding
33.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-2.62
Book Value
$4.73
P/E Ratio
-10.1x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.